Chromatin-associated RNA sequencing (ChAR-seq) maps genome-wide RNA-to-DNA contacts
Abstract
RNA is a critical component of chromatin in eukaryotes, both as a product of transcription, and as an essential constituent of ribonucleoprotein complexes that regulate both local and global chromatin states. Here we present a proximity ligation and sequencing method called Chromatin-Associated RNA sequencing (ChAR-seq) that maps all RNA-to-DNA contacts across the genome. Using Drosophila cells we show that ChAR-seq provides unbiased, de novo identification of targets of chromatin-bound RNAs including nascent transcripts, chromosome-specific dosage compensation ncRNAs, and genome-wide trans-associated RNAs involved in co-transcriptional RNA processing.
Data availability
All sequence data has been deposited in GEO under accession number GSE97131The software analysis pipeline is available at https://gitlab.com/charseq/flypipe
-
Chromatin-associated RNA sequencing (ChAR-seq) maps genome-wide RNA-to-DNA contactsPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE97131).
-
Domain ChIRP reveals the modularity of long noncoding RNA architecture, function, and target genesPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE53020).
-
High-Affinity Sites Form an Interaction Network to Facilitate Spreading of the MSL Complex across the X Chromosome in DrosophilaPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE58821).
-
GRID-seq reveals the global RNA-chromatin interactomePublicly available at the NCBI Gene Expression Omnibus (accession no: GSE82312).
Article and author information
Author details
Funding
National Institutes of Health (Stanford Center for Systems Biology (NIH P50 GM107615) Seed Grant)
- Jason C Bell
- David Jukam
- Viviana I Risca
- Whitney L Johnson
Howard Hughes Medical Institute (HHMI-Simons Faculty Scholar Award)
- Jan M Skotheim
National Institutes of Health (P50HG00773501)
- William James Greenleaf
National Institutes of Health (R01GM106005)
- Aaron F Straight
Stanford University School of Medicine (Dean's Fellowship)
- Jason C Bell
National Institutes of Health (R01HG009909)
- William James Greenleaf
- Aaron F Straight
National Institutes of Health (R21HG007726)
- William James Greenleaf
National Institutes of Health (NIH Ruth Kirchstein National Research Service Award (F32GM116338))
- Jason C Bell
National Institutes of Health (NIH Ruth Kirchstein National Research Service Award (F32GM108295 ))
- David Jukam
Stanford University (Walter V. and Idun Berry Fellowship)
- Viviana I Risca
National Institutes of Health (Stanford Genetics Training Program (5T32HG000044-19))
- Nicole A Teran
National Institutes of Health (Molecular Pharmacology Training Grant (NIH T32-GM113854-02))
- Owen K Smith
National Institutes of Health (NIH T32 Training Fellowship (GM007276))
- Whitney L Johnson
National Science Foundation (DGE-114747)
- Whitney L Johnson
National Institutes of Health (RO1 HD085135)
- Jan M Skotheim
- Aaron F Straight
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2018, Bell et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 17,114
- views
-
- 2,311
- downloads
-
- 130
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
- Neuroscience
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
-
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.